Overview
Merchants Bancorp Q3 net income falls 11% yr/yr, but rises 44% from Q2 2025
Q3 diluted EPS of $0.97, down 17% yr/yr, up 62% from Q2 2025
Company executed credit default swap on $557 mln healthcare loan pool
Outlook
Company did not provide specific financial guidance for future quarters in press release
Result Drivers
CREDIT QUALITY IMPROVEMENT - Decrease in provision for credit losses by 45% contributed to improved net interest income after provisions
LOAN SALES STRENGTH - Gain on sale of loans increased by 47% compared to Q3 2024, highlighting core business resilience
RISK MANAGEMENT - Execution of a credit default swap on a $557 mln healthcare loan pool to reduce risk-based capital requirements
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 EPS
$0.97
Q3 Net Income
$54.70 mln
Q3 Net Interest Income
$128.05 mln
Q3 Basic EPS
$0.97
Q3 Credit Loss Provision
$29.23 mln
Q3 Pretax Profit
$64.58 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the banks peer group is "buy"
Wall Street's median 12-month price target for Merchants Bancorp is $40.00, about 19.1% above its October 27 closing price of $32.36
The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 7 three months ago
Press Release: ID:nPnrYnbDa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)